Fundraising Fox
Rani Therapeutics
NASDAQ: RANISan Jose, US · Founded 2012 · California LLC · 4 known investors
Find your way into Rani Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
180 people can intro you to Talat
Ask Lyn Baranowski to introduce you to Talat Imran
You →Lyn · together at Rani Therapeutics →Talat
Sign up to find every way you can get introduced to Rani Therapeutics
- Your email: who you already know at Rani Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Rani Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Rani Therapeutics develops oral drug delivery technology using robotic capsules to replace injectable biotherapeutics, addressing the challenge of delivering biologics through the gastrointestinal tract without needles. The company targets patients with chronic conditions who currently require painful injections.
Founders & leadership
TI
Talat ImranChief Executive OfficerHe previously worked as a managing director at InCube Ventures and VHM Ventures, and holds a bachelor's degree in computer science.
Board
MI
AF
Investors · 4
GV (Google Ventures)listed by GV (Google Ventures)Mountain View · $250K – $50M
How we know: GV (Google Ventures)'s portfolio page · a partner's Signal profile · Not right? Tell us
InCube Ventureslisted by InCube VenturesSan Jose
How we know: InCube Ventures's portfolio page · Not right? Tell us
RA CapitalreportedBoston
How we know: funding news · Not right? Tell us
VHMinferredSan Jose
How we know: board seat on SEC Form D · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$111.8M disclosed across 4 rounds · 2015–2020
▶$50MraisedNov 2020 · 2 investors · BiotechnologyRule 506(b)
▶$50MraisedNov 2020 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Svai SanfordExecutive Officer
- Maulik NanavatyDirector
- Andrew FarquharsonDirector
- Mir HashimExecutive Officer, Director
- Mir ImranExecutive Officer, Director
- Dennis AusielloDirector
- Offering amount
- $75M
- Amount sold
- $50M
- Minimum investment
- $1
- First sale
- Oct 2020
- Incorporated
- Limited Liability Company, California
- Federal exemptions
- 06b
▶$38.7MraisedSep 2017 · 12 investors · Other Health CareRule 506(b)
▶$38.7MraisedSep 2017 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mir ImranExecutive Officer, Director
- David PyottDirector
- Mir HashimExecutive Officer, Director
- Andrew FarquharsonDirector
- Maulik NanavatyDirector
- Offering amount
- $126.5M
- Amount sold
- $38.7M
- Minimum investment
- $1
- Sales commissions
- $172K
- Placement agents
- Joseph Gunnar & Co. LLC
- First sale
- Aug 2017
- Incorporated
- Limited Liability Company, California, 2012
- Federal exemptions
- 06b
▶$15.5MraisedJun 2015 · 10 investors · Other Health CareRule 506(b)
▶$15.5MraisedJun 2015 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mir HashimExecutive Officer, Director
- Mir ImranExecutive Officer, Director
- Andrew FarquharsonDirector
- Offering amount
- $52.3M
- Amount sold
- $15.5M
- Minimum investment
- $1
- First sale
- May 2015
- Incorporated
- Limited Liability Company, California, 2012
- Federal exemptions
- 06b
▶$7.7MraisedJun 2015 · 2 investors · Other Health CareRule 506(b)
▶$7.7MraisedJun 2015 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mir ImranExecutive Officer, Director
- Mir HashimExecutive Officer, Director
- Andrew FarquharsonDirector
- Offering amount
- $15M
- Amount sold
- $7.7M
- Minimum investment
- $1
- Sales commissions
- $320K
- Placement agents
- Joseph Gunnar & Co. LLC
- First sale
- May 2015
- Incorporated
- Limited Liability Company, California, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$206.1Mvaluation at IPOAug 2021 · $11.00/share · 424B4
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Founder mafia
2 people who came through Rani Therapeutics went on to found or lead other companies.
Related companies · 8
RobinhoodRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
PublicPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.
TradingViewTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
NasdaqNasdaq operates a technology infrastructure platform for financial markets across three business segments: Capital Access Platforms (which includes listing services, indices, and analytics tools), Financial Technology (comprising compliance, regulatory, and capital markets software), and Market Services (equities and derivatives trading operations). The company serves financial institutions, listed companies, investment managers, and regulatory agencies globally.
Simply Wall StSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
StockTwitsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
TipRanksFinancial analysis and stock research platform.
Companies working in the same space as Rani Therapeutics.
Frequently asked questions
- What does Rani Therapeutics do?
- Rani Therapeutics develops oral drug delivery technology using robotic capsules to replace injectable biotherapeutics, addressing the challenge of delivering biologics through the gastrointestinal tract without needles. The company targets patients with chronic conditions who currently require painful injections.
- Who are Rani Therapeutics's investors?
- Rani Therapeutics's investors include GV (Google Ventures), InCube Ventures, RA Capital, VHM.
- How much funding has Rani Therapeutics raised?
- Rani Therapeutics has disclosed $111.8M raised across 4 rounds.
- Where is Rani Therapeutics headquartered?
- Rani Therapeutics is headquartered in San Jose, US.